NCT00630097View on ClinicalTrials.gov

A Dose Ranging Study of Modafinil for Methamphetamine Dependence

PHASE2UnknownINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Substance DependenceAmphetamine Dependence

Interventions

DRUG

modafinil

Modafinil, 100mg, 400mg, or 600 mg tablets QD for 4 weeks.

Trial Locations (1)

94110

CPMC, San Francisco

Sponsors

Lead Sponsor

California Pacific Medical Center Research Institute

All Listed Sponsors

lead

California Pacific Medical Center Research Institute

OTHER

NCT00630097 - A Dose Ranging Study of Modafinil for Methamphetamine Dependence | Biotech Hunter | Biotech Hunter